カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界の血清がんバイオマーカー市場2022年：肝細胞癌血清バイオマーカー、肺癌血清バイオマーカー、膵臓＆胆道癌血清バイオマーカー、乳癌血清バイオマーカー、神経膠芽腫血清バイオマーカー、その他

◆英語タイトル：Global Serum Cancer Biomarkers Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22MY8960 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年5月（※2025年版があります。お問い合わせください。） ◆ページ数：104 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

血清がんバイオマーカー市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の血清がんバイオマーカーの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

血清がんバイオマーカー市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・肝細胞癌血清バイオマーカー、肺癌血清バイオマーカー、膵臓＆胆道癌血清バイオマーカー、乳癌血清バイオマーカー、神経膠芽腫血清バイオマーカー、その他

用途別セグメントは次のように区分されます。
・病院、学術研究機関、外来外科センター、その他

世界の血清がんバイオマーカー市場の主要な市場プレーヤーは以下のとおりです。
・Roche、Pfizer、Novartis、Abbott、BD、Merck、Eli Lilly、Agilent Technologies、Boehringer Ingelheim、AstraZeneca、Bristol-Myers Squibb、Novo Nordisk、Allergan、Gilead

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、血清がんバイオマーカー製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な血清がんバイオマーカーメーカーの企業概要、2019年～2022年までの血清がんバイオマーカーの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な血清がんバイオマーカーメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別血清がんバイオマーカーの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの血清がんバイオマーカーの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での血清がんバイオマーカー市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および血清がんバイオマーカーの産業チェーンを掲載しています。
・第13、14、15章では、血清がんバイオマーカーの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Roche、Pfizer、Novartis、Abbott、BD、Merck、Eli Lilly、Agilent Technologies、Boehringer Ingelheim、AstraZeneca、Bristol-Myers Squibb、Novo Nordisk、Allergan、Gilead
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：肝細胞癌血清バイオマーカー、肺癌血清バイオマーカー、膵臓＆胆道癌血清バイオマーカー、乳癌血清バイオマーカー、神経膠芽腫血清バイオマーカー、その他
・用途別分析2017年-2028年：病院、学術研究機関、外来外科センター、その他
・血清がんバイオマーカーの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・血清がんバイオマーカーのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・血清がんバイオマーカーのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・血清がんバイオマーカーの南米市場規模2017年-2028年：ブラジル、アルゼンチン
・血清がんバイオマーカーの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Serum Cancer Biomarkers market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Serum Cancer Biomarkers market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Serum Cancer Biomarkers global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Hepatocellular Carcinoma Serum Biomarkers segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Serum Cancer Biomarkers include Roche, Pfizer, Novartis, Abbott, and BD, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Serum Cancer Biomarkers market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Hepatocellular Carcinoma Serum Biomarkers
Lung Cancer Serum Biomarkers
Pancreatic & Biliary Tract Cancer Serum Biomarkers
Breast Cancer Serum Biomarkers
Glioblastoma Serum Biomarkers
Others
Market segment by Application can be divided into
Hospitals
Academic & Research Institutes
Ambulatory Surgical Centers
Others
The key market players for global Serum Cancer Biomarkers market are listed below:
Roche
Pfizer
Novartis
Abbott
BD
Merck
Eli Lilly
Agilent Technologies
Boehringer Ingelheim
AstraZeneca
Bristol-Myers Squibb
Novo Nordisk
Allergan
Gilead
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Serum Cancer Biomarkers product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Serum Cancer Biomarkers, with price, sales, revenue and global market share of Serum Cancer Biomarkers from 2019 to 2022.
Chapter 3, the Serum Cancer Biomarkers competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Serum Cancer Biomarkers breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Serum Cancer Biomarkers market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Serum Cancer Biomarkers.
Chapter 13, 14, and 15, to describe Serum Cancer Biomarkers sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Serum Cancer Biomarkers Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Serum Cancer Biomarkers Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Hepatocellular Carcinoma Serum Biomarkers
1.2.3 Lung Cancer Serum Biomarkers
1.2.4 Pancreatic & Biliary Tract Cancer Serum Biomarkers
1.2.5 Breast Cancer Serum Biomarkers
1.2.6 Glioblastoma Serum Biomarkers
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Serum Cancer Biomarkers Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Academic & Research Institutes
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Global Serum Cancer Biomarkers Market Size & Forecast
1.4.1 Global Serum Cancer Biomarkers Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Serum Cancer Biomarkers Sales in Volume (2017-2028)
1.4.3 Global Serum Cancer Biomarkers Price (2017-2028)
1.5 Global Serum Cancer Biomarkers Production Capacity Analysis
1.5.1 Global Serum Cancer Biomarkers Total Production Capacity (2017-2028)
1.5.2 Global Serum Cancer Biomarkers Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Serum Cancer Biomarkers Market Drivers
1.6.2 Serum Cancer Biomarkers Market Restraints
1.6.3 Serum Cancer Biomarkers Trends Analysis
2 Manufacturers Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Serum Cancer Biomarkers Product and Services
2.1.4 Roche Serum Cancer Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Serum Cancer Biomarkers Product and Services
2.2.4 Pfizer Serum Cancer Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Serum Cancer Biomarkers Product and Services
2.3.4 Novartis Serum Cancer Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Abbott
2.4.1 Abbott Details
2.4.2 Abbott Major Business
2.4.3 Abbott Serum Cancer Biomarkers Product and Services
2.4.4 Abbott Serum Cancer Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 BD
2.5.1 BD Details
2.5.2 BD Major Business
2.5.3 BD Serum Cancer Biomarkers Product and Services
2.5.4 BD Serum Cancer Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business
2.6.3 Merck Serum Cancer Biomarkers Product and Services
2.6.4 Merck Serum Cancer Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Eli Lilly
2.7.1 Eli Lilly Details
2.7.2 Eli Lilly Major Business
2.7.3 Eli Lilly Serum Cancer Biomarkers Product and Services
2.7.4 Eli Lilly Serum Cancer Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Agilent Technologies
2.8.1 Agilent Technologies Details
2.8.2 Agilent Technologies Major Business
2.8.3 Agilent Technologies Serum Cancer Biomarkers Product and Services
2.8.4 Agilent Technologies Serum Cancer Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Boehringer Ingelheim
2.9.1 Boehringer Ingelheim Details
2.9.2 Boehringer Ingelheim Major Business
2.9.3 Boehringer Ingelheim Serum Cancer Biomarkers Product and Services
2.9.4 Boehringer Ingelheim Serum Cancer Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 AstraZeneca
2.10.1 AstraZeneca Details
2.10.2 AstraZeneca Major Business
2.10.3 AstraZeneca Serum Cancer Biomarkers Product and Services
2.10.4 AstraZeneca Serum Cancer Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Bristol-Myers Squibb
2.11.1 Bristol-Myers Squibb Details
2.11.2 Bristol-Myers Squibb Major Business
2.11.3 Bristol-Myers Squibb Serum Cancer Biomarkers Product and Services
2.11.4 Bristol-Myers Squibb Serum Cancer Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Novo Nordisk
2.12.1 Novo Nordisk Details
2.12.2 Novo Nordisk Major Business
2.12.3 Novo Nordisk Serum Cancer Biomarkers Product and Services
2.12.4 Novo Nordisk Serum Cancer Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Allergan
2.13.1 Allergan Details
2.13.2 Allergan Major Business
2.13.3 Allergan Serum Cancer Biomarkers Product and Services
2.13.4 Allergan Serum Cancer Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Gilead
2.14.1 Gilead Details
2.14.2 Gilead Major Business
2.14.3 Gilead Serum Cancer Biomarkers Product and Services
2.14.4 Gilead Serum Cancer Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Serum Cancer Biomarkers Breakdown Data by Manufacturer
3.1 Global Serum Cancer Biomarkers Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Serum Cancer Biomarkers Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Serum Cancer Biomarkers
3.4 Market Concentration Rate
3.4.1 Top 3 Serum Cancer Biomarkers Manufacturer Market Share in 2021
3.4.2 Top 6 Serum Cancer Biomarkers Manufacturer Market Share in 2021
3.5 Global Serum Cancer Biomarkers Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Serum Cancer Biomarkers Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Serum Cancer Biomarkers Market Size by Region
4.1.1 Global Serum Cancer Biomarkers Sales in Volume by Region (2017-2028)
4.1.2 Global Serum Cancer Biomarkers Revenue by Region (2017-2028)
4.2 North America Serum Cancer Biomarkers Revenue (2017-2028)
4.3 Europe Serum Cancer Biomarkers Revenue (2017-2028)
4.4 Asia-Pacific Serum Cancer Biomarkers Revenue (2017-2028)
4.5 South America Serum Cancer Biomarkers Revenue (2017-2028)
4.6 Middle East and Africa Serum Cancer Biomarkers Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Serum Cancer Biomarkers Sales in Volume by Type (2017-2028)
5.2 Global Serum Cancer Biomarkers Revenue by Type (2017-2028)
5.3 Global Serum Cancer Biomarkers Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Serum Cancer Biomarkers Sales in Volume by Application (2017-2028)
6.2 Global Serum Cancer Biomarkers Revenue by Application (2017-2028)
6.3 Global Serum Cancer Biomarkers Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Serum Cancer Biomarkers Sales by Type (2017-2028)
7.2 North America Serum Cancer Biomarkers Sales by Application (2017-2028)
7.3 North America Serum Cancer Biomarkers Market Size by Country
7.3.1 North America Serum Cancer Biomarkers Sales in Volume by Country (2017-2028)
7.3.2 North America Serum Cancer Biomarkers Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Serum Cancer Biomarkers Sales by Type (2017-2028)
8.2 Europe Serum Cancer Biomarkers Sales by Application (2017-2028)
8.3 Europe Serum Cancer Biomarkers Market Size by Country
8.3.1 Europe Serum Cancer Biomarkers Sales in Volume by Country (2017-2028)
8.3.2 Europe Serum Cancer Biomarkers Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Serum Cancer Biomarkers Sales by Type (2017-2028)
9.2 Asia-Pacific Serum Cancer Biomarkers Sales by Application (2017-2028)
9.3 Asia-Pacific Serum Cancer Biomarkers Market Size by Region
9.3.1 Asia-Pacific Serum Cancer Biomarkers Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Serum Cancer Biomarkers Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Serum Cancer Biomarkers Sales by Type (2017-2028)
10.2 South America Serum Cancer Biomarkers Sales by Application (2017-2028)
10.3 South America Serum Cancer Biomarkers Market Size by Country
10.3.1 South America Serum Cancer Biomarkers Sales in Volume by Country (2017-2028)
10.3.2 South America Serum Cancer Biomarkers Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Serum Cancer Biomarkers Sales by Type (2017-2028)
11.2 Middle East & Africa Serum Cancer Biomarkers Sales by Application (2017-2028)
11.3 Middle East & Africa Serum Cancer Biomarkers Market Size by Country
11.3.1 Middle East & Africa Serum Cancer Biomarkers Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Serum Cancer Biomarkers Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Serum Cancer Biomarkers and Key Manufacturers
12.2 Manufacturing Costs Percentage of Serum Cancer Biomarkers
12.3 Serum Cancer Biomarkers Production Process
12.4 Serum Cancer Biomarkers Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Serum Cancer Biomarkers Typical Distributors
13.3 Serum Cancer Biomarkers Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Serum Cancer Biomarkers Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Serum Cancer Biomarkers Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Roche Basic Information, Manufacturing Base and Competitors
Table 4. Roche Major Business
Table 5. Roche Serum Cancer Biomarkers Product and Services
Table 6. Roche Serum Cancer Biomarkers Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Major Business
Table 9. Pfizer Serum Cancer Biomarkers Product and Services
Table 10. Pfizer Serum Cancer Biomarkers Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Novartis Basic Information, Manufacturing Base and Competitors
Table 12. Novartis Major Business
Table 13. Novartis Serum Cancer Biomarkers Product and Services
Table 14. Novartis Serum Cancer Biomarkers Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Abbott Basic Information, Manufacturing Base and Competitors
Table 16. Abbott Major Business
Table 17. Abbott Serum Cancer Biomarkers Product and Services
Table 18. Abbott Serum Cancer Biomarkers Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. BD Basic Information, Manufacturing Base and Competitors
Table 20. BD Major Business
Table 21. BD Serum Cancer Biomarkers Product and Services
Table 22. BD Serum Cancer Biomarkers Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Merck Basic Information, Manufacturing Base and Competitors
Table 24. Merck Major Business
Table 25. Merck Serum Cancer Biomarkers Product and Services
Table 26. Merck Serum Cancer Biomarkers Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 28. Eli Lilly Major Business
Table 29. Eli Lilly Serum Cancer Biomarkers Product and Services
Table 30. Eli Lilly Serum Cancer Biomarkers Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Agilent Technologies Basic Information, Manufacturing Base and Competitors
Table 32. Agilent Technologies Major Business
Table 33. Agilent Technologies Serum Cancer Biomarkers Product and Services
Table 34. Agilent Technologies Serum Cancer Biomarkers Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 36. Boehringer Ingelheim Major Business
Table 37. Boehringer Ingelheim Serum Cancer Biomarkers Product and Services
Table 38. Boehringer Ingelheim Serum Cancer Biomarkers Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 40. AstraZeneca Major Business
Table 41. AstraZeneca Serum Cancer Biomarkers Product and Services
Table 42. AstraZeneca Serum Cancer Biomarkers Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 44. Bristol-Myers Squibb Major Business
Table 45. Bristol-Myers Squibb Serum Cancer Biomarkers Product and Services
Table 46. Bristol-Myers Squibb Serum Cancer Biomarkers Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 48. Novo Nordisk Major Business
Table 49. Novo Nordisk Serum Cancer Biomarkers Product and Services
Table 50. Novo Nordisk Serum Cancer Biomarkers Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Allergan Basic Information, Manufacturing Base and Competitors
Table 52. Allergan Major Business
Table 53. Allergan Serum Cancer Biomarkers Product and Services
Table 54. Allergan Serum Cancer Biomarkers Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Gilead Basic Information, Manufacturing Base and Competitors
Table 56. Gilead Major Business
Table 57. Gilead Serum Cancer Biomarkers Product and Services
Table 58. Gilead Serum Cancer Biomarkers Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Global Serum Cancer Biomarkers Sales by Manufacturer (2019, 2020, 2021, and 2022) & (MT)
Table 60. Global Serum Cancer Biomarkers Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 61. Market Position of Manufacturers in Serum Cancer Biomarkers, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 62. Global Serum Cancer Biomarkers Production Capacity by Company, (MT): 2020 VS 2021
Table 63. Head Office and Serum Cancer Biomarkers Production Site of Key Manufacturer
Table 64. Serum Cancer Biomarkers New Entrant and Capacity Expansion Plans
Table 65. Serum Cancer Biomarkers Mergers & Acquisitions in the Past Five Years
Table 66. Global Serum Cancer Biomarkers Sales by Region (2017-2022) & (MT)
Table 67. Global Serum Cancer Biomarkers Sales by Region (2023-2028) & (MT)
Table 68. Global Serum Cancer Biomarkers Revenue by Region (2017-2022) & (USD Million)
Table 69. Global Serum Cancer Biomarkers Revenue by Region (2023-2028) & (USD Million)
Table 70. Global Serum Cancer Biomarkers Sales by Type (2017-2022) & (MT)
Table 71. Global Serum Cancer Biomarkers Sales by Type (2023-2028) & (MT)
Table 72. Global Serum Cancer Biomarkers Revenue by Type (2017-2022) & (USD Million)
Table 73. Global Serum Cancer Biomarkers Revenue by Type (2023-2028) & (USD Million)
Table 74. Global Serum Cancer Biomarkers Price by Type (2017-2022) & (USD/MT)
Table 75. Global Serum Cancer Biomarkers Price by Type (2023-2028) & (USD/MT)
Table 76. Global Serum Cancer Biomarkers Sales by Application (2017-2022) & (MT)
Table 77. Global Serum Cancer Biomarkers Sales by Application (2023-2028) & (MT)
Table 78. Global Serum Cancer Biomarkers Revenue by Application (2017-2022) & (USD Million)
Table 79. Global Serum Cancer Biomarkers Revenue by Application (2023-2028) & (USD Million)
Table 80. Global Serum Cancer Biomarkers Price by Application (2017-2022) & (USD/MT)
Table 81. Global Serum Cancer Biomarkers Price by Application (2023-2028) & (USD/MT)
Table 82. North America Serum Cancer Biomarkers Sales by Country (2017-2022) & (MT)
Table 83. North America Serum Cancer Biomarkers Sales by Country (2023-2028) & (MT)
Table 84. North America Serum Cancer Biomarkers Revenue by Country (2017-2022) & (USD Million)
Table 85. North America Serum Cancer Biomarkers Revenue by Country (2023-2028) & (USD Million)
Table 86. North America Serum Cancer Biomarkers Sales by Type (2017-2022) & (MT)
Table 87. North America Serum Cancer Biomarkers Sales by Type (2023-2028) & (MT)
Table 88. North America Serum Cancer Biomarkers Sales by Application (2017-2022) & (MT)
Table 89. North America Serum Cancer Biomarkers Sales by Application (2023-2028) & (MT)
Table 90. Europe Serum Cancer Biomarkers Sales by Country (2017-2022) & (MT)
Table 91. Europe Serum Cancer Biomarkers Sales by Country (2023-2028) & (MT)
Table 92. Europe Serum Cancer Biomarkers Revenue by Country (2017-2022) & (USD Million)
Table 93. Europe Serum Cancer Biomarkers Revenue by Country (2023-2028) & (USD Million)
Table 94. Europe Serum Cancer Biomarkers Sales by Type (2017-2022) & (MT)
Table 95. Europe Serum Cancer Biomarkers Sales by Type (2023-2028) & (MT)
Table 96. Europe Serum Cancer Biomarkers Sales by Application (2017-2022) & (MT)
Table 97. Europe Serum Cancer Biomarkers Sales by Application (2023-2028) & (MT)
Table 98. Asia-Pacific Serum Cancer Biomarkers Sales by Region (2017-2022) & (MT)
Table 99. Asia-Pacific Serum Cancer Biomarkers Sales by Region (2023-2028) & (MT)
Table 100. Asia-Pacific Serum Cancer Biomarkers Revenue by Region (2017-2022) & (USD Million)
Table 101. Asia-Pacific Serum Cancer Biomarkers Revenue by Region (2023-2028) & (USD Million)
Table 102. Asia-Pacific Serum Cancer Biomarkers Sales by Type (2017-2022) & (MT)
Table 103. Asia-Pacific Serum Cancer Biomarkers Sales by Type (2023-2028) & (MT)
Table 104. Asia-Pacific Serum Cancer Biomarkers Sales by Application (2017-2022) & (MT)
Table 105. Asia-Pacific Serum Cancer Biomarkers Sales by Application (2023-2028) & (MT)
Table 106. South America Serum Cancer Biomarkers Sales by Country (2017-2022) & (MT)
Table 107. South America Serum Cancer Biomarkers Sales by Country (2023-2028) & (MT)
Table 108. South America Serum Cancer Biomarkers Revenue by Country (2017-2022) & (USD Million)
Table 109. South America Serum Cancer Biomarkers Revenue by Country (2023-2028) & (USD Million)
Table 110. South America Serum Cancer Biomarkers Sales by Type (2017-2022) & (MT)
Table 111. South America Serum Cancer Biomarkers Sales by Type (2023-2028) & (MT)
Table 112. South America Serum Cancer Biomarkers Sales by Application (2017-2022) & (MT)
Table 113. South America Serum Cancer Biomarkers Sales by Application (2023-2028) & (MT)
Table 114. Middle East & Africa Serum Cancer Biomarkers Sales by Region (2017-2022) & (MT)
Table 115. Middle East & Africa Serum Cancer Biomarkers Sales by Region (2023-2028) & (MT)
Table 116. Middle East & Africa Serum Cancer Biomarkers Revenue by Region (2017-2022) & (USD Million)
Table 117. Middle East & Africa Serum Cancer Biomarkers Revenue by Region (2023-2028) & (USD Million)
Table 118. Middle East & Africa Serum Cancer Biomarkers Sales by Type (2017-2022) & (MT)
Table 119. Middle East & Africa Serum Cancer Biomarkers Sales by Type (2023-2028) & (MT)
Table 120. Middle East & Africa Serum Cancer Biomarkers Sales by Application (2017-2022) & (MT)
Table 121. Middle East & Africa Serum Cancer Biomarkers Sales by Application (2023-2028) & (MT)
Table 122. Serum Cancer Biomarkers Raw Material
Table 123. Key Manufacturers of Serum Cancer Biomarkers Raw Materials
Table 124. Direct Channel Pros & Cons
Table 125. Indirect Channel Pros & Cons
Table 126. Serum Cancer Biomarkers Typical Distributors
Table 127. Serum Cancer Biomarkers Typical Customers
List of Figures
Figure 1. Serum Cancer Biomarkers Picture
Figure 2. Global Serum Cancer Biomarkers Revenue Market Share by Type in 2021
Figure 3. Hepatocellular Carcinoma Serum Biomarkers
Figure 4. Lung Cancer Serum Biomarkers
Figure 5. Pancreatic & Biliary Tract Cancer Serum Biomarkers
Figure 6. Breast Cancer Serum Biomarkers
Figure 7. Glioblastoma Serum Biomarkers
Figure 8. Others
Figure 9. Global Serum Cancer Biomarkers Revenue Market Share by Application in 2021
Figure 10. Hospitals
Figure 11. Academic & Research Institutes
Figure 12. Ambulatory Surgical Centers
Figure 13. Others
Figure 14. Global Serum Cancer Biomarkers Revenue, (USD Million) & (MT): 2017 & 2021 & 2028
Figure 15. Global Serum Cancer Biomarkers Revenue and Forecast (2017-2028) & (USD Million)
Figure 16. Global Serum Cancer Biomarkers Sales (2017-2028) & (MT)
Figure 17. Global Serum Cancer Biomarkers Price (2017-2028) & (USD/MT)
Figure 18. Global Serum Cancer Biomarkers Production Capacity (2017-2028) & (MT)
Figure 19. Global Serum Cancer Biomarkers Production Capacity by Geographic Region: 2022 VS 2028
Figure 20. Serum Cancer Biomarkers Market Drivers
Figure 21. Serum Cancer Biomarkers Market Restraints
Figure 22. Serum Cancer Biomarkers Market Trends
Figure 23. Global Serum Cancer Biomarkers Sales Market Share by Manufacturer in 2021
Figure 24. Global Serum Cancer Biomarkers Revenue Market Share by Manufacturer in 2021
Figure 25. Serum Cancer Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 26. Top 3 Serum Cancer Biomarkers Manufacturer (Revenue) Market Share in 2021
Figure 27. Top 6 Serum Cancer Biomarkers Manufacturer (Revenue) Market Share in 2021
Figure 28. Global Serum Cancer Biomarkers Sales Market Share by Region (2017-2028)
Figure 29. Global Serum Cancer Biomarkers Revenue Market Share by Region (2017-2028)
Figure 30. North America Serum Cancer Biomarkers Revenue (2017-2028) & (USD Million)
Figure 31. Europe Serum Cancer Biomarkers Revenue (2017-2028) & (USD Million)
Figure 32. Asia-Pacific Serum Cancer Biomarkers Revenue (2017-2028) & (USD Million)
Figure 33. South America Serum Cancer Biomarkers Revenue (2017-2028) & (USD Million)
Figure 34. Middle East & Africa Serum Cancer Biomarkers Revenue (2017-2028) & (USD Million)
Figure 35. Global Serum Cancer Biomarkers Sales Market Share by Type (2017-2028)
Figure 36. Global Serum Cancer Biomarkers Revenue Market Share by Type (2017-2028)
Figure 37. Global Serum Cancer Biomarkers Price by Type (2017-2028) & (USD/MT)
Figure 38. Global Serum Cancer Biomarkers Sales Market Share by Application (2017-2028)
Figure 39. Global Serum Cancer Biomarkers Revenue Market Share by Application (2017-2028)
Figure 40. Global Serum Cancer Biomarkers Price by Application (2017-2028) & (USD/MT)
Figure 41. North America Serum Cancer Biomarkers Sales Market Share by Type (2017-2028)
Figure 42. North America Serum Cancer Biomarkers Sales Market Share by Application (2017-2028)
Figure 43. North America Serum Cancer Biomarkers Sales Market Share by Country (2017-2028)
Figure 44. North America Serum Cancer Biomarkers Revenue Market Share by Country (2017-2028)
Figure 45. United States Serum Cancer Biomarkers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Canada Serum Cancer Biomarkers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Mexico Serum Cancer Biomarkers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Europe Serum Cancer Biomarkers Sales Market Share by Type (2017-2028)
Figure 49. Europe Serum Cancer Biomarkers Sales Market Share by Application (2017-2028)
Figure 50. Europe Serum Cancer Biomarkers Sales Market Share by Country (2017-2028)
Figure 51. Europe Serum Cancer Biomarkers Revenue Market Share by Country (2017-2028)
Figure 52. Germany Serum Cancer Biomarkers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. France Serum Cancer Biomarkers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. United Kingdom Serum Cancer Biomarkers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Russia Serum Cancer Biomarkers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Italy Serum Cancer Biomarkers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Asia-Pacific Serum Cancer Biomarkers Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Serum Cancer Biomarkers Sales Market Share by Application (2017-2028)
Figure 59. Asia-Pacific Serum Cancer Biomarkers Sales Market Share by Region (2017-2028)
Figure 60. Asia-Pacific Serum Cancer Biomarkers Revenue Market Share by Region (2017-2028)
Figure 61. China Serum Cancer Biomarkers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Japan Serum Cancer Biomarkers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Korea Serum Cancer Biomarkers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. India Serum Cancer Biomarkers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Southeast Asia Serum Cancer Biomarkers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Australia Serum Cancer Biomarkers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. South America Serum Cancer Biomarkers Sales Market Share by Type (2017-2028)
Figure 68. South America Serum Cancer Biomarkers Sales Market Share by Application (2017-2028)
Figure 69. South America Serum Cancer Biomarkers Sales Market Share by Country (2017-2028)
Figure 70. South America Serum Cancer Biomarkers Revenue Market Share by Country (2017-2028)
Figure 71. Brazil Serum Cancer Biomarkers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Argentina Serum Cancer Biomarkers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Middle East & Africa Serum Cancer Biomarkers Sales Market Share by Type (2017-2028)
Figure 74. Middle East & Africa Serum Cancer Biomarkers Sales Market Share by Application (2017-2028)
Figure 75. Middle East & Africa Serum Cancer Biomarkers Sales Market Share by Region (2017-2028)
Figure 76. Middle East & Africa Serum Cancer Biomarkers Revenue Market Share by Region (2017-2028)
Figure 77. Turkey Serum Cancer Biomarkers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Egypt Serum Cancer Biomarkers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Saudi Arabia Serum Cancer Biomarkers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. South Africa Serum Cancer Biomarkers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Manufacturing Cost Structure Analysis of Serum Cancer Biomarkers in 2021
Figure 82. Manufacturing Process Analysis of Serum Cancer Biomarkers
Figure 83. Serum Cancer Biomarkers Industrial Chain
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
Figure 85. Methodology
Figure 86. Research Process and Data Source

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の血清がんバイオマーカー市場2022年：肝細胞癌血清バイオマーカー、肺癌血清バイオマーカー、膵臓＆胆道癌血清バイオマーカー、乳癌血清バイオマーカー、神経膠芽腫血清バイオマーカー、その他(Global Serum Cancer Biomarkers Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界の血清がんバイオマーカー市場2022年：肝細胞癌血清バイオマーカー、肺癌血清バイオマーカー、膵臓＆胆道癌血清バイオマーカー、乳癌血清バイオマーカー、神経膠芽腫血清バイオマーカー、その他

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp